Dr. Judy Peih-Ying Tsai
Claim this profileCleveland Clinic Akron General
Studies Lung Cancer
Studies Non-Small Cell Lung Cancer
10 reported clinical trials
25 drugs studied
Area of expertise
1Lung Cancer
Stage III
Stage II
Stage I
2Non-Small Cell Lung Cancer
Stage III
Stage II
Stage I
Affiliated Hospitals
Clinical Trials Judy Peih-Ying Tsai is currently running
Genetic Testing
for Early-Stage Lung Cancer
This ALCHEMIST trial studies genetic testing in screening patients with stage IB-IIIA non-small cell lung cancer that has been or will be removed by surgery. Studying the genes in a patient's tumor cells may help doctors select the best treatment for patients that have certain genetic changes.
Recruiting0 awards N/A4 criteria
Chemotherapy + Bevacizumab + Atezolizumab
for Colorectal Cancer
This phase III trial studies how well combination chemotherapy, bevacizumab, and/or atezolizumab work in treating patients with deficient deoxyribonucleic acid (DNA) mismatch repair colorectal cancer that has spread from where it first started (primary site) to other places in the body (metastatic). Chemotherapy drugs, such as fluorouracil, oxaliplatin, and leucovorin calcium, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Bevacizumab may stop or slow colorectal cancer by blocking the growth of new blood vessels necessary for tumor growth. Immunotherapy with monoclonal antibodies, such as atezolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Giving combination chemotherapy, bevacizumab, and atezolizumab may work better in treating patients with colorectal cancer.
Recruiting2 awards Phase 31 criteria
More about Judy Peih-Ying Tsai
Clinical Trial Related4 years of experience running clinical trials · Led 10 trials as a Principal Investigator · 7 Active Clinical TrialsTreatments Judy Peih-Ying Tsai has experience with
- Fluorouracil
- Oxaliplatin
- Pembrolizumab
- Biospecimen Collection
- Durvalumab
- Cabozantinib S-malate
Breakdown of trials Judy Peih-Ying Tsai has run
Lung Cancer
Non-Small Cell Lung Cancer
Cancer
Colorectal Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Judy Peih-Ying Tsai specialize in?
Judy Peih-Ying Tsai focuses on Lung Cancer and Non-Small Cell Lung Cancer. In particular, much of their work with Lung Cancer has involved Stage III patients, or patients who are Stage II.
Is Judy Peih-Ying Tsai currently recruiting for clinical trials?
Yes, Judy Peih-Ying Tsai is currently recruiting for 6 clinical trials in Akron Ohio. If you're interested in participating, you should apply.
Are there any treatments that Judy Peih-Ying Tsai has studied deeply?
Yes, Judy Peih-Ying Tsai has studied treatments such as Fluorouracil, Oxaliplatin, Pembrolizumab.
What is the best way to schedule an appointment with Judy Peih-Ying Tsai?
Apply for one of the trials that Judy Peih-Ying Tsai is conducting.
What is the office address of Judy Peih-Ying Tsai?
The office of Judy Peih-Ying Tsai is located at: Cleveland Clinic Akron General, Akron, Ohio 44307 United States. This is the address for their practice at the Cleveland Clinic Akron General.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.